Latest Market Engagement News

Vitrafy Life Sciences has achieved a major validation milestone with US Army-backed Phase II results showing its no-wash platelet cryopreservation protocol delivers 94% post-thaw recovery, outperforming existing standards and advancing FDA registration plans.

AnteoTech has secured independent validation of its Ultranode™ 95 silicon anode in commercial-format battery cells, demonstrating over 40% higher energy density and strong cycle life, advancing its push into the growing drone battery market.

TruScreen Group Limited has kicked off a NZ$2.9 million capital raising combining a NZ$1 million placement and a NZ$1.94 million rights issue to fund its global expansion and regulatory compliance efforts. The company reported a 42% jump in product sales for FY2026 and is targeting major public health programs across 14 countries.

Titomic Limited has landed a contract worth over AUD 1.2 million from Lufthansa Technik AG to supply additional cold spray equipment to its Hamburg facility, reinforcing its foothold in aerospace additive manufacturing.

Encounter Resources has achieved strong metallurgical recoveries of 51-53% niobium and up to 57% Nb2O5 concentrate grade from the Green deposit at its Aileron Project, validating conventional processing methods and supporting multi-decade mining potential.

Aldoro Resources has reported its longest continuous mineralised intercept at the Kameelburg project in Namibia, delivering 503.98 metres at 1.30% TREO and confirming robust multi-commodity mineralisation on the eastern flank of the carbonatite.

Xenitra Limited's OPAL Real World Asset tokenised sales ecosystem has generated over $500,000 in sales within its first month, onboarding more than 130 distributors and positioning the company as an early mover in blockchain-enabled FMCG sales in China.

Australian Mines has reaffirmed strong economics for its Flemington Scandium Project, highlighting a robust 28-year mine life and significant leverage to scandium price scenarios.

REA Group delivered robust Q3 FY26 results, driven by double-digit revenue growth in Australia and record engagement on realestate.com.au, while lowering its cost growth guidance for FY26.

Entropy Neurodynamics has bolstered its intellectual property portfolio with a new US provisional patent application for TRP-8803, following compelling Phase 2a data showing a 75% response rate in treatment-resistant IBS patients.

Ava Risk Group posted a $6.1 million Q3 sales intake and secured a $7 million strategic investment to fuel US expansion, while geopolitical tensions delay some Middle East orders.

AKORA Resources has secured a 25-year mining permit for its flagship Bekisopa iron ore project, a critical step toward development, but faces suspension from ASX quotation due to late reporting.